Postmortem reports revealed that in subjects with early AD, BDNF expression was not altered while TrkB expression was increased in hippocampus [14], whereas both BDNF and TrkB levels were reduced in cerebral cortex and hippocampus of patients with a severe AD pathology [15]. This evidence concerns the gene NTRK2 and Alzheimer disease.